Tag: biotechnology
-
Moderna Funding University Immunology Research
A biotechnology enterprise is financing a collaboration with Harvard Medical School that aims to discover new mechanisms for treating immune system disorders.
-
Synthetic Biology Platform Designed for Vaccines
Researchers in France and the U.K. developed a modular technology with synthetic and computational biology for designing vaccines against infectious diseases.
-
Cannabis Epilepsy Treatment Approved in Europe
The European Commission yesterday endorsed a recommendation to market in Europe a cannabis-based treatment for seizures from two rare forms of epilepsy.
-
Biotech Developing Genome-Adjusting Disease Treatments
A new biotechnology enterprise is creating disease treatments that address regions in the genome precisely regulating expression of proteins.
-
First Therapies Selected for Multi-Drug ALS Trial
A clinical trial is getting underway to test five treatment candidates for amyotrophic lateral sclerosis, or ALS, beginning with the first three therapies.
-
Start-Up Targets Extra DNA in Cancer, Raises $46.4M
A new biotechnology enterprise is developing treatments for aggressive solid tumor cancers that block the effects of DNA residing outside of chromosomes.
-
Gel, Crispr Help Defeat Cancer Drug Obstacles
A high-powered binding protein, formulated as a gel and targeted by Crispr gene editing is shown in lab mice to precisely deliver drugs and kill cancer cells.
-
Gene-Editing Biotech Gains $34M in Early Funds
A two year-old enterprise spun-off from Yale University is developing gene-editing treatments for genetic disorders with synthetic peptides and DNA delivered in nanoscale particles.
-
Experimental Drug Shown to Prevent Memory Loss
A drug candidate designed to compensate for damage to brain cells from toxic proteins prevented nerve cell damage and memory loss in lab mice.
-
Response by Patients Shown to Precision Lung Cancer Drug
Results of a clinical trial show a treatment targeting specific genetic aberrations produces a therapeutic response in most patients with lung cancer from that condition.